SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : Politics for Pros- moderated -- Ignore unavailable to you. Want to Upgrade?


To: DMaA who wrote (606093)8/25/2016 9:56:38 PM
From: Alan Smithee  Read Replies (1) | Respond to of 794387
 
Bullshit.

I pay $3.50 for a month's supply of Lisinopril.

Mylan can set the price wherever it wants.



To: DMaA who wrote (606093)8/26/2016 11:15:51 AM
From: D. Long1 Recommendation

Recommended By
Thehammer

  Respond to of 794387
 
What I think she's saying is that with high deductible plans people are paying more of the market price, instead of a co-pay, and hence are more aware of the shocking high cost of drugs.



To: DMaA who wrote (606093)8/27/2016 10:24:09 AM
From: skinowski5 Recommendations

Recommended By
alanrs
D. Long
DMaA
gamesmistress
Thehammer

  Read Replies (1) | Respond to of 794387
 
One more on the EpiPen story. Corruption at its best.

Government funds awarded to Mylan, Inc. increased dramatically after the daughter of Sen. Joe Manchin (D., W.Va.) took over as its chief executive officer.

freebeacon.com

And, the boss's compensation goes from 2.5 mil in 2007 to almost 19 mil this year. Cool.